MyChesCo on MSN9h
FDA Approves Groundbreaking Cell Therapy for Life-Threatening Pediatric Disease
A seismic shift in pediatric medical care has arrived with the FDA’s approval of Ryoncil (remestemcel-L-rknd), a ...
healthday13h
FDA Approves Ryoncil for Steroid-Refractory Acute Graft-Versus-Host After Allo-HSCT
The allogeneic bone marrow-derived mesenchymal stromal cell (MSC) therapy Ryoncil (remestemcel-L-rknd) has been approv ...
MedPage Today14h
Stem Cell Transplantation Still the Main Treatment Option for Beta-Thalassemia
While gene therapy has emerged as a promising alternative for treating beta-thalassemia, hematopoietic stem cell ...
Pharmabiz22h
Meiji Seika Pharma establishes local subsidiary “Taiwan Meiji Pharma Co., Ltd.” in Taiwan
Meiji Seika Pharma establishes local subsidiary “Taiwan Meiji Pharma Co., Ltd.” in Taiwan: Tokyo Friday, December 27, 2024, 13:00 Hrs [IST] Meiji Seika Pharma Co., Ltd., a pha ...